Pune, India -- (SBWire) -- 08/27/2018 --Global Cardiac Catheterization Market - Overview
Cardiac Catheterization is a widely used procedure in different cardiovascular surgeries. This procedure involves insertion of a small tube into a chamber or vessel of the heart. It is the most commonly used technique for the diagnosis and treatment of cardiac diseases.
According to a recent study published by the Market Research Future analysts, the Global Cardiac Catheterization Market is growing at a moderate growth rate; mainly due to increasing number of people suffering from cardiac diseases leading to the requirement of surgical procedures. The factors that are responsible for driving the growth of the market are rising occurrence of cardiovascular diseases, growing number of cardiac surgeries, a high number of diabetic and obese population, huge geriatric population, and changing living standards leading to development of cardiac disorders.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/972
On the other hand, availability of alternative therapies, and the higher cost of the surgeries are some of the obstacles in growth of this market. Moreover, high risk of development of infection due to the catheterization procedures is further hindering the growth of the market.
Global Cardiac Catheterization Market – Top Players
Boston Scientific Corporation
Coloplast
Dispocard GmbH
Becton
Dickinson and Company
St. Jude Medical
Abbott
Johnson & Johnson Private Limited and more.
Global Cardiac Catheterization Market - Segments
Global Cardiac Catheterization market has been segmented on the basis of types and applications. By types which majorly include Angiographic Balloon Catheter, Arterial Embolectomy, Bipolar Pacing Shrouded Pin, Hexapolar Balloon Pacing, Optical Fiber Scope, Semi Flotating Electrode and Others. Whereas by applications includes Coronary angiogram, Right heart catheterization, Heart biopsy, Balloon angioplasty, Valve replacement and others.
Cardiac catheterization is a widely used procedure in different cardiovascular surgeries. This procedure involves insertion of a small tube into a chamber or vessel of the heart. It is the most commonly used technique for the diagnosis and treatment of cardiac diseases.
Get Discount @ https://www.marketresearchfuture.com/check-discount/972
Industry News:
In November 2017, Abbott announced the approval of its MitraClip device for treatment of people with mitral regurgitation (MR) from Japan's Ministry of Health, Labour and Welfare (MHLW).
In May 2017, Abbott announced the CE Mark of the "TactiCath Contact Force Ablation Catheter, Sensor Enabled". The product is developed to make it easier for physicians to more effectively treat atrial fibrillation (AF).
In March 2017, Abbott announced U.S. Food and Drug Administration (FDA) approval of the "FlexAbility Ablation Catheter, Sensor Enabled" designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter, a type of irregular heartbeat.
In January 2017, Abbott announced the U.S. launch and the first commercial uses of the new "EnSite Precision cardiac mapping system" and "Advisor FL Circular Mapping Catheter, Sensor Enabled" to map cardiac arrhythmias during ablation treatments.
Global Cardiac Catheterization Market - Regional Analysis
Owing to the presence of huge patients suffering from cardiovascular diseases, America dominates the global cardiac catheterization market. According to the Centers for Disease Control and Prevention, 28.4 million adults were suffering from heart diseases by January 2017. Increasing number of patients suffering from heart diseases and increasing healthcare expenditure have driven the growth of the market.
Europe accounts for the second largest market due to continuously increasing patient population, well-developed healthcare sector, high healthcare expenditure, and government support for the research and development.
Asia Pacific is the fastest growing market; according to the World Health Organization (WHO), 60% of total world diabetic population lives in Asia Pacific region. Diabetes is one of the major risk factors for causing heart diseases. Increasing patients suffering from diabetes and heart diseases have stimulated the growth of the market.
The Middle East & Africa has the lowest market for the cardiac catheterization; however, the Middle East is the major contributor in this region due to the presence of well-developed economies like Kuwait and Qatar. On the other hand, because of limited development in the field of medical science and existence of economically poor countries, the market is limited in Africa.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/972
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Cardiac Catheterization Market to Register High Growth at a CAGR of 9.2% by MRFR Till 2023